Interestingly, D@C-LPs successfully bound to CLDN4 proteins that had become superficially exposed in pancreatic cancer owing to disruption of tight junctions, but showed reduced accumulation in the normal pancreas because access to CLDN4 in these tissues is hindered by intact tight junctions. Here, CLDN4 is linked to pancreatic neoplasm.